Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2021 December;73(6) > Minerva Urology and Nephrology 2021 December;73(6):870-2

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

EDITORIAL COMMENT   Free accessfree

Minerva Urology and Nephrology 2021 December;73(6):870-2

DOI: 10.23736/S2724-6051.21.04817-5

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough?

Fabio TURCO 1, Marcello TUCCI 2, Consuelo BUTTIGLIERO 1

1 Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy; 2 Department of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy



inizio pagina